{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:19:53Z","timestamp":1791987593245,"version":"4.4.0"},"reference-count":296,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T00:00:00Z","timestamp":1582243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009980","name":"Medizinische Universit\u00e4t Innsbruck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009980","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00249","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T07:02:32Z","timestamp":1582268552000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":146,"title":["Inflammation-Induced Tryptophan Breakdown is Related With Anemia, Fatigue, and Depression in Cancer"],"prefix":"10.3389","volume":"11","author":[{"given":"Lukas","family":"Lanser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Kink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Maria","family":"Egger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Willenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenter","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Kurz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0306-9877(03)00002-1","article-title":"Neopterin as a potential modulator of tumor cell growth and proliferation","volume":"60","author":"Rieder","year":"2003","journal-title":"Med Hypotheses."},{"key":"B2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/cas.13171","article-title":"Predictive and prognostic role of serum neopterin and tryptophan breakdown in prostate cancer","volume":"108","author":"Pichler","year":"2017","journal-title":"Cancer Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1158\/1078-0432.CCR-14-1860","article-title":"Immune escape mechanisms as a guide for cancer immunotherapy","volume":"21","author":"Beatty","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41416-019-0664-6","article-title":"The therapeutic potential of targeting tryptophan catabolism in cancer","volume":"122","author":"Opitz","year":"2020","journal-title":"Br J Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.18632\/oncotarget.1504","article-title":"Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia","volume":"5","author":"Folgiero","year":"2014","journal-title":"Oncotarget"},{"key":"B6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3109\/10428194.2015.1041388","article-title":"High serum concentration of L-kynurenine predicts unfavorable outcomes in patients with acute myeloid leukemia","volume":"57","author":"Mabuchi","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.3109\/10428194.2014.953150","article-title":"Expression of indoleamine 2,3-dioxygenase in leukemic cells indicates an unfavorable prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics","volume":"56","author":"Fukuno","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"B8","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.leukres.2008.06.014","article-title":"Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients' sera by HPLC and is inducible by IFN-gamma","volume":"33","author":"Corm","year":"2009","journal-title":"Leuk Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.3324\/haematol.13112","article-title":"High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome","volume":"93","author":"Chamuleau","year":"2008","journal-title":"Haematologica."},{"key":"B10","first-page":"539","article-title":"[Indoleamine 2, 3-dioxygenase activity in acute myeloid leukemia cells contributing to tumor immune escape]","volume":"14","author":"Tang","year":"2006","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"B11","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3389\/fimmu.2018.00724","article-title":"High indoleamine 2,3-dioxygenase is correlated with microvessel density and worse prognosis in breast cancer","volume":"9","author":"Wei","year":"2018","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/00365513.2018.1542541","article-title":"The decrease of some serum free amino acids can predict breast cancer diagnosis and progression","volume":"79","author":"Eniu","year":"2019","journal-title":"Scandinav J Clin Lab Investig"},{"key":"B13","doi-asserted-by":"publisher","first-page":"6506","DOI":"10.18632\/oncotarget.6467","article-title":"Understanding the role of the kynurenine pathway in human breast cancer immunobiology","volume":"7","author":"Heng","year":"2016","journal-title":"Oncotarget"},{"key":"B14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1756-0500-4-156","article-title":"Tryptophan degradation in women with breast cancer: a pilot study","volume":"4","author":"Lyon","year":"2011","journal-title":"BMC Research Notes"},{"key":"B15","doi-asserted-by":"publisher","first-page":"6511","DOI":"10.1007\/s13277-014-1859-3","article-title":"IDO is highly expressed in breast cancer and breast cancer-derived circulating microvesicles and associated to aggressive types of tumors by in silico analysis","volume":"35","author":"Isla Larrain","year":"2014","journal-title":"Tumor Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/172460080902400408","article-title":"Immune system modulation in patients with malignant and benign breast disorders: tryptophan degradation and serum neopterin","volume":"24","author":"Girgin","year":"2009","journal-title":"Int J Biol Markers"},{"key":"B17","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s13058-014-0410-1","article-title":"Cancer\/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression","volume":"16","author":"Chen","year":"2014","journal-title":"Breast Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00262-013-1393-y","article-title":"Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry","volume":"62","author":"Soliman","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"B19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/ijc.25979","article-title":"High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma","volume":"130","author":"Jacquemier","year":"2012","journal-title":"Int J Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"469135","DOI":"10.1155\/2011\/469135","article-title":"Upregulated expression of indoleamine 2, 3-dioxygenase in primary breast cancer correlates with increase of infiltrated regulatory T cells in situ and lymph node metastasis","volume":"2011","author":"Yu","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/bjc.2011.513","article-title":"Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer","volume":"106","author":"Ferdinande","year":"2012","journal-title":"Br J Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.3748\/wjg.v22.i13.3592","article-title":"Relationship between indoleamine 2,3-dioxygenase activity and lymphatic invasion propensity of colorectal carcinoma","volume":"22","author":"Engin","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1479-5876-7-71","article-title":"The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer","volume":"7","author":"Gao","year":"2009","journal-title":"J Transl Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1038\/sj.bjc.6600336","article-title":"Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer","volume":"86","author":"Huang","year":"2002","journal-title":"Br J Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1158\/1078-0432.CCR-05-1966","article-title":"Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells","volume":"12","author":"Brandacher","year":"2006","journal-title":"Clin Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/ijc.29481","article-title":"Low expression of Bin1, along with high expression of IDO in tumor tissue and draining lymph nodes, are predictors of poor prognosis for esophageal squamous cell cancer patients","volume":"137","author":"Jia","year":"2015","journal-title":"Int J Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3109\/08820139509066843","article-title":"Decreased serum tryptophan in patients with cancer cachexia correlates with increased serum neopterin","volume":"24","author":"Iwagaki","year":"1995","journal-title":"Immunol Invest."},{"key":"B28","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.oraloncology.2011.03.007","article-title":"Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas","volume":"47","author":"Laimer","year":"2011","journal-title":"Oral Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"384726","DOI":"10.1155\/2011\/384726","article-title":"Involvement of indoleamine 2,3-dioxygenase in impairing tumor-infiltrating CD8 T-cell functions in esophageal squamous cell carcinoma","volume":"2011","author":"Zhang","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e112945","DOI":"10.1371\/journal.pone.0112945","article-title":"Involvement of the kynurenine pathway in human glioma pathophysiology","volume":"9","author":"Adams","year":"2014","journal-title":"PLoS ONE"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/j.jocn.2015.06.018","article-title":"The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy","volume":"22","author":"Zhai","year":"2015","journal-title":"J Clin Neurosci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1227\/NEU.0b013e31828cf945","article-title":"Expression of indoleamine 2,3-dioxygenase and correlation with pathological malignancy in gliomas","volume":"72","author":"Mitsuka","year":"2013","journal-title":"Neurosurgery."},{"key":"B33","doi-asserted-by":"publisher","first-page":"6110","DOI":"10.1158\/1078-0432.CCR-12-2130","article-title":"IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival","volume":"18","author":"Wainwright","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.3389\/fimmu.2018.01598","article-title":"Indoleamine 2,3-dioxygenase expression pattern in the tumor microenvironment predicts clinical outcome in early stage cervical cancer","volume":"9","author":"Heeren","year":"2018","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ygyno.2018.02.020","article-title":"Immunobiochemical pathways of neopterin formation and tryptophan breakdown via indoleamine 2,3-dioxygenase correlate with circulating tumor cells in ovarian cancer patients- A study of the OVCAD consortium","volume":"149","author":"Gostner","year":"2018","journal-title":"Gynecol Oncol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ygyno.2012.05.034","article-title":"Prognostic role of indoleamine 2,3-dioxygenase in endometrial carcinoma","volume":"126","author":"de Jong","year":"2012","journal-title":"Gynecol Oncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e981457","DOI":"10.4161\/2162402X.2014.981457","article-title":"Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival","volume":"4","author":"Ferns","year":"2015","journal-title":"Oncoimmunology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ygyno.2010.02.028","article-title":"Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy","volume":"117","author":"Inaba","year":"2010","journal-title":"Gynecol Oncol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.imbio.2010.07.010","article-title":"Enhanced tryptophan degradation in patients with ovarian carcinoma correlates with several serum soluble immune activation markers","volume":"216","author":"Sperner-Unterweger","year":"2011","journal-title":"Immunobiology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ygyno.2009.07.015","article-title":"Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma","volume":"115","author":"Inaba","year":"2009","journal-title":"Gynecol Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1097\/IGC.0b013e31822017fb","article-title":"Serum tryptophan and kynurenine concentrations as parameters for indoleamine 2,3-dioxygenase activity in patients with endometrial, ovarian, and vulvar cancer","volume":"21","author":"de Jong","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1158\/1078-0432.CCR-07-4144","article-title":"Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: its association with disease progression and survival","volume":"14","author":"Ino","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B43","first-page":"2629","article-title":"Systemic changes of tryptophan catabolites via the indoleamine-2,3-dioxygenase pathway in primary cervical cancer","volume":"31","author":"Fotopoulou","year":"2011","journal-title":"Anticancer Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"6030","DOI":"10.1158\/1078-0432.CCR-04-2671","article-title":"Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells","volume":"11","author":"Okamoto","year":"2005","journal-title":"Clin Cancer Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3892\/or.17.6.1333","article-title":"Increased synthesis of indoleamine-2,3-dioxygenase protein is positively associated with impaired survival in patients with serous-type, but not with other types of, ovarian cancer","volume":"17","author":"Takao","year":"2007","journal-title":"Oncol Rep."},{"key":"B46","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.canlet.2004.10.033","article-title":"Tryptophan degradation in patients with gynecological cancer correlates with immune activation","volume":"223","author":"Schroecksnadel","year":"2005","journal-title":"Cancer Lett"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/sj.bjc.6603477","article-title":"Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer","volume":"95","author":"Ino","year":"2006","journal-title":"Br J Cancer"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1111\/cas.13811","article-title":"Mechanism and prognostic value of indoleamine 2,3-dioxygenase 1 expressed in hepatocellular carcinoma","volume":"109","author":"Li","year":"2018","journal-title":"Cancer Sci"},{"key":"B49","doi-asserted-by":"publisher","first-page":"10466","DOI":"10.1038\/srep10466","article-title":"Prognostic significance of kynurenine 3-monooxygenase and effects on proliferation, migration, and invasion of human hepatocellular carcinoma","volume":"5","author":"Jin","year":"2015","journal-title":"Sci Rep"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s00432-008-0395-1","article-title":"Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma","volume":"134","author":"Pan","year":"2008","journal-title":"J Cancer Res Clin Oncol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1440-1746.2003.03259.x","article-title":"Immunoactivative role of indoleamine 2,3-dioxygenase in human hepatocellular carcinoma","volume":"19","author":"Ishio","year":"2004","journal-title":"J Gastroenterol Hepatol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"66540","DOI":"10.18632\/oncotarget.11658","article-title":"Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer","volume":"7","author":"Trott","year":"2016","journal-title":"Oncotarget"},{"key":"B53","doi-asserted-by":"publisher","first-page":"461.e15","DOI":"10.1016\/j.urolonc.2017.02.011","article-title":"Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma","volume":"35","author":"Lucarelli","year":"2017","journal-title":"Urol Oncol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"6993","DOI":"10.1158\/1078-0432.CCR-07-0942","article-title":"Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma","volume":"13","author":"Riesenberg","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3969\/j.issn.1672-7347.2012.07.001","article-title":"Indoleamine-pyrrole 2,3-dioxygenase might be a prognostic biomarker for patients with renal cell carcinoma","volume":"37","author":"Yuan","year":"2012","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"B56","doi-asserted-by":"publisher","first-page":"54548","DOI":"10.18632\/oncotarget.17408","article-title":"P53 prevent tumor invasion and metastasis by down-regulating IDO in lung cancer","volume":"8","author":"Tang","year":"2017","journal-title":"Oncotarget"},{"key":"B57","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1158\/1055-9965.EPI-13-0770","article-title":"Circulating biomarkers of tryptophan and the kynurenine pathway and lung cancer risk","volume":"23","author":"Chuang","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32555","article-title":"Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3)","author":"Huang","year":"2019","journal-title":"Int J Cancer."},{"key":"B59","doi-asserted-by":"publisher","first-page":"27584","DOI":"10.18632\/oncotarget.8488","article-title":"Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2\/kynurenine axis","volume":"7","author":"Hsu","year":"2016","journal-title":"Oncotarget"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e23428","DOI":"10.4161\/onci.23428","article-title":"Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancer","volume":"2","author":"Creelan","year":"2013","journal-title":"Oncoimmunology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.4161\/cbt.6.8.4446","article-title":"Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer","volume":"6","author":"Karanikas","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e36956","DOI":"10.1371\/journal.pone.0036956","article-title":"Fatigue in patients with lung cancer is related with accelerated tryptophan breakdown","volume":"7","author":"Kurz","year":"2012","journal-title":"PLoS ONE"},{"key":"B63","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1593\/neo.04658","article-title":"Eosinophil granulocytes account for indoleamine 2,3-dioxygenase-mediated immune escape in human non-small cell lung cancer","volume":"7","author":"Astigiano","year":"2005","journal-title":"Neoplasia"},{"key":"B64","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/j.1365-2354.2009.01122.x","article-title":"Increased tryptophan degradation in patients with bronchus carcinoma","volume":"19","author":"Engin","year":"","journal-title":"Eur J Cancer Care. ("},{"key":"B65","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.lungcan.2009.05.001","article-title":"Increased serum kynurenine\/tryptophan ratio correlates with disease progression in lung cancer","volume":"67","author":"Suzuki","year":"2010","journal-title":"Lung Cancer"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3109\/10428194.2015.1117610","article-title":"An increase in indoleamine 2,3-dioxygenase-positive cells in the tumor microenvironment predicts favorable prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone","volume":"57","author":"Nam","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1158\/1078-0432.CCR-14-2275","article-title":"Prognostic significance of tryptophan catabolism in adult T-cell leukemia\/lymphoma","volume":"21","author":"Masaki","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B68","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3109\/10428194.2013.804917","article-title":"Up-regulated expression of indoleamine 2,3-dioxygenase 1 in non-Hodgkin lymphoma correlates with increased regulatory T-cell infiltration","volume":"55","author":"Liu","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"B69","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1600-0609.2009.01393.x","article-title":"Serum concentration of L-kynurenine predicts the clinical outcome of patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"84","author":"Yoshikawa","year":"2010","journal-title":"Eur J Haematol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/1471-2407-14-335","article-title":"Indoleamine 2,3-dioxygenase (IDO) is frequently expressed in stromal cells of Hodgkin lymphoma and is associated with adverse clinical features: a retrospective cohort study","volume":"14","author":"Choe","year":"2014","journal-title":"BMC Cancer"},{"key":"B71","first-page":"699","article-title":"Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy\/tropical spastic paraparesis, and adult T-cell leukemia\/lymphoma","volume":"5","author":"Giusti","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"B72","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00277-010-1093-z","article-title":"Indoleamine 2,3-dioxygenase in tumor tissue indicates prognosis in patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"90","author":"Ninomiya","year":"2011","journal-title":"Ann Hematol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.leukres.2008.05.023","article-title":"Indoleamine 2,3-dioxygenase is highly expressed in human adult T-cell leukemia\/lymphoma and chemotherapy changes tryptophan catabolism in serum and reduced activity","volume":"33","author":"Hoshi","year":"2009","journal-title":"Leuk Res"},{"key":"B74","doi-asserted-by":"publisher","first-page":"376","DOI":"10.5114\/pjp.2015.57249","article-title":"The prognostic significance of indoleamine-2,3-dioxygenase and the receptors for transforming growth factor beta and interferon gamma in metastatic lymph nodes in malignant melanoma","volume":"66","author":"Pelak","year":"2015","journal-title":"Pol J Pathol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000096906","article-title":"Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients","volume":"214","author":"Weinlich","year":"2007","journal-title":"Dermatology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.amjoto.2014.08.009","article-title":"FoxP3 and indoleamine 2,3-dioxygenase immunoreactivity in sentinel nodes from melanoma patients","volume":"35","author":"Ryan","year":"2014","journal-title":"Am J Otolaryngol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0006-3223(03)00173-2","article-title":"Interferon-alpha-induced changes in tryptophan metabolism: relationship to depression and paroxetine treatment","volume":"54","author":"Capuron","year":"2003","journal-title":"Biol Psychiatry."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.ejca.2011.09.007","article-title":"Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients","volume":"48","author":"Speeckaert","year":"2012","journal-title":"Eur J Cancer"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.4161\/cc.8.12.8745","article-title":"Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival","volume":"8","author":"Brody","year":"2009","journal-title":"Cell Cycle"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s10585-009-9290-7","article-title":"Prognostic value of indoleamine 2,3-dioxygenase expression in high grade osteosarcoma","volume":"26","author":"Urakawa","year":"2009","journal-title":"Clin Exp Metast"},{"key":"B81","doi-asserted-by":"publisher","first-page":"710","DOI":"10.4103\/0366-6999.201613","article-title":"Expression and prognostic value of indoleamine 2,3-dioxygenase in pancreatic cancer","volume":"130","author":"Zhang","year":"2017","journal-title":"Chin Med J."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e0196465","DOI":"10.1371\/journal.pone.0196465","article-title":"A prospective evaluation of serum kynurenine metabolites and risk of pancreatic cancer","volume":"13","author":"Huang","year":"2018","journal-title":"PLoS ONE"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1016\/j.ejca.2008.05.023","article-title":"High expression of indoleamine 2,3-dioxygenase gene in prostate cancer","volume":"44","author":"Feder-Mengus","year":"2008","journal-title":"Eur J Cancer"},{"key":"B84","doi-asserted-by":"publisher","first-page":"E832","DOI":"10.1210\/jc.2013-3351","article-title":"Indoleamine 2,3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment","volume":"99","author":"Moretti","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B85","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00432-007-0191-3","article-title":"Diminished quality of life in patients with cancer correlates with tryptophan degradation","volume":"133","author":"Schroecksnadel","year":"2007","journal-title":"J Cancer Res Clin Oncol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B87","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00262-004-0653-2","article-title":"Tumor antigen-specific T helper cells in cancer immunity and immunotherapy","volume":"54","author":"Knutson","year":"2005","journal-title":"Cancer Immunol Immunother"},{"key":"B88","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2174\/1389200024605082","article-title":"Neopterin as a marker for immune system activation","volume":"3","author":"Murr","year":"2002","journal-title":"Curr Drug Metab."},{"key":"B89","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/BF00210961","article-title":"Weight loss in patients with hematological neoplasias is associated with immune system stimulation","volume":"71","author":"Denz","year":"1993","journal-title":"Clin Investig."},{"key":"B90","article-title":"Tryptophan and phenylalanine metabolism and depression in patients with solid tumors","volume-title":"Pteridines, 38th International Winter-Workshop Clinical, Chemical and Biochemical Aspects of Pteridines and Related Topics Innsbruck, February 26th\u2013March 1st, 2019","author":"Kink","year":"2019"},{"key":"B91","doi-asserted-by":"publisher","first-page":"280","DOI":"10.21037\/atm.2017.06.29","article-title":"Neopterin as a biomarker of immune response in cancer patients","volume":"5","author":"Melichar","year":"2017","journal-title":"Ann Transl Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/BF01990503","article-title":"Interferons and indoleamine 2,3-dioxygenase: role in antimicrobial and antitumor effects","volume":"45","author":"Carlin","year":"1989","journal-title":"Experientia."},{"key":"B93","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2217\/imt-2016-0118","article-title":"Modulation of cancer-specific immune responses by amino acid degrading enzymes","volume":"9","author":"Timosenko","year":"2017","journal-title":"Immunotherapy"},{"key":"B94","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1179\/1607845414Y.0000000161","article-title":"Anemia in malignancies: pathogenetic and diagnostic considerations","volume":"20","author":"Gaspar","year":"2015","journal-title":"Hematology"},{"key":"B95","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0093-7754(01)90207-6","article-title":"Fatigue: a main component of anemia symptomatology","volume":"28","author":"Sobrero","year":"2001","journal-title":"Semin Oncol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0959-8049(98)00167-1","article-title":"Fatigue in patients with cancer","volume":"34","author":"Stone","year":"1998","journal-title":"Eur J Cancer."},{"key":"B97","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/0973-1075.53507","article-title":"Fatigue in cancer: a review of literature","volume":"15","author":"Narayanan","year":"2009","journal-title":"Indian J Palliat Care"},{"key":"B98","first-page":"82","article-title":"Exercise, inflammation, and fatigue in cancer survivors","volume":"22","author":"LaVoy","year":"2016","journal-title":"Exerc Immunol Rev."},{"key":"B99","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/S1470-2045(11)70002-X","article-title":"Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies","volume":"12","author":"Mitchell","year":"2011","journal-title":"Lancet Oncol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2010.07.034","article-title":"The prevalence and pharmacotherapy of depression in cancer patients","volume":"131","author":"Ng","year":"2011","journal-title":"J Affect Disord"},{"key":"B101","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jad.2012.03.025","article-title":"Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age","volume":"141","author":"Linden","year":"2012","journal-title":"J Affect Disord"},{"key":"B102","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/978-1-4684-5952-4_32","article-title":"Tryptophan nutrition and metabolism: an overview","volume":"294","author":"Peters","year":"1991","journal-title":"Adv Exp Med Biol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4137\/IJTR.S2129","article-title":"L-Tryptophan: basic metabolic functions, behavioral research and therapeutic indications","volume":"2","author":"Richard","year":"2009","journal-title":"Int J Tryptophan Res."},{"key":"B104","doi-asserted-by":"publisher","first-page":"13231","DOI":"10.1073\/pnas.1209919109","article-title":"Control of cyclooxygenase-2 expression and tumorigenesis by endogenous 5-methoxytryptophan","volume":"109","author":"Cheng","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B105","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1098\/rstb.2012.0109","article-title":"The 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouse","volume":"367","author":"Jacobsen","year":"2012","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/nn1964","article-title":"Long story short: the serotonin transporter in emotion regulation and social cognition","volume":"10","author":"Canli","year":"2007","journal-title":"Nat Neurosci"},{"key":"B107","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","article-title":"The expanded biology of serotonin","volume":"60","author":"Berger","year":"2009","journal-title":"Annu Rev Med"},{"key":"B108","doi-asserted-by":"publisher","first-page":"12281","DOI":"10.1074\/jbc.271.21.12281","article-title":"Metabolism of serotonin to N-acetylserotonin, melatonin, and 5-methoxytryptamine in hamster skin culture","volume":"271","author":"Slominski","year":"1996","journal-title":"J Biol Chem"},{"key":"B109","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuchi.2015.03.002","article-title":"Melatonin: physiological effects in humans","volume":"61","author":"Claustrat","year":"2015","journal-title":"Neurochirurgie"},{"key":"B110","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0301-0082(82)90023-5","article-title":"Tryptamine: a neuromodulator or neurotransmitter in mammalian brain?","volume":"19","author":"Jones","year":"1982","journal-title":"Prog Neurobiol."},{"key":"B111","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0021-9258(19)84026-7","article-title":"Enzymic synthesis of niacin nucleotides from 3-hydroxyanthranilic acid in mammalian liver","volume":"238","author":"Nishizuka","year":"1963","journal-title":"J Biol Chem."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.cmet.2018.03.018","article-title":"Quantitative analysis of NAD synthesis-breakdown fluxes","volume":"27","author":"Liu","year":"2018","journal-title":"Cell metabolism."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1093\/jn\/100.12.1471","article-title":"Evidence for a linear correlation between the level of dietary tryptophan and hepatic NAD concentration and for a systematic variation in tissue NAD concentration in the mouse and the rat","volume":"100","author":"Powanda","year":"1970","journal-title":"J Nutr"},{"key":"B114","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0021-9258(19)50968-1","article-title":"The conversion of tryptophan to kynurenine in liver. II. The enzymatic hydrolysis of formylkynurenine","volume":"187","author":"Mehler","year":"1950","journal-title":"J Biol Chem."},{"key":"B115","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1006\/abbi.2000.1755","article-title":"Heme: a regulator of rat hepatic tryptophan 2,3-dioxygenase?","volume":"377","author":"Ren","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"B116","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/j.1460-2075.1987.tb04800.x","article-title":"Glucocorticoid induction of the rat tryptophan oxygenase gene is mediated by two widely separated glucocorticoid-responsive elements","volume":"6","author":"Danesch","year":"1987","journal-title":"EMBO J."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1178646917691938","DOI":"10.1177\/1178646917691938","article-title":"Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects","volume":"10","author":"Badawy","year":"2017","journal-title":"Int J Tryptophan Res."},{"key":"B118","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fimmu.2018.00151","article-title":"The role of indoleamine-2,3-dioxygenase in cancer development, diagnostics, and therapy","volume":"9","author":"Hornyak","year":"2018","journal-title":"Front Immunol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3389\/fimmu.2014.00497","article-title":"AhR-mediated, non-genomic modulation of IDO1 function","volume":"5","author":"Pallotta","year":"2014","journal-title":"Front Immunol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.bbrc.2008.07.156","article-title":"Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase","volume":"375","author":"Vogel","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"B121","doi-asserted-by":"publisher","first-page":"19961","DOI":"10.1073\/pnas.1014465107","article-title":"Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism","volume":"107","author":"Nguyen","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B122","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1158\/2326-6066.CIR-16-0400","article-title":"Constitutive IDO1 expression in human tumors is driven by cyclooxygenase-2 and mediates intrinsic immune resistance","volume":"5","author":"Hennequart","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1182\/blood.V83.5.1408.1408","article-title":"Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes","volume":"83","author":"Musso","year":"1994","journal-title":"Blood."},{"key":"B124","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/1521-4141(200102)31:2<333::aid-immu333>3.0.co;2-x","article-title":"IL-4 and IL-13 regulate the induction of indoleamine 2,3-dioxygenase activity and the control of Toxoplasma gondii replication in human fibroblasts activated with IFN-gamma","volume":"31","author":"Chaves","year":"2001","journal-title":"Eur J Immunol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/bs.ircmb.2017.07.004","article-title":"Indoleamine 2,3-dioxygenase and its therapeutic inhibition in cancer","volume":"336","author":"Prendergast","year":"2018","journal-title":"Int Rev Cell Mol Biol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.1038\/emm.2014.69","article-title":"Heme-binding-mediated negative regulation of the tryptophan metabolic enzyme indoleamine 2,3-dioxygenase 1 (IDO1) by IDO2","volume":"46","author":"Lee","year":"2014","journal-title":"Exp Mol Med"},{"key":"B127","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00702-011-0681-y","article-title":"The kynurenine system and immunoregulation","volume":"119","author":"Mandi","year":"","journal-title":"J Neural Transm. ("},{"key":"B128","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/978-1-4615-0135-0_50","article-title":"Tryptophan pyrrole ring cleavage enzymes in placenta","volume":"527","author":"Minatogawa","year":"2003","journal-title":"Adv Exp Med Biol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jri.2003.11.004","article-title":"Indoleamine 2,3-dioxygenase: distribution and function in the developing human placenta","volume":"61","author":"Kudo","year":"2004","journal-title":"J Reprod Immunol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1042\/bj3550425","article-title":"Expression of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase in early concepti","volume":"355","author":"Suzuki","year":"2001","journal-title":"Biochem J."},{"key":"B131","doi-asserted-by":"publisher","first-page":"e00261","DOI":"10.1042\/BSR20150197","article-title":"Tryptophan metabolism, disposition and utilization in pregnancy","volume":"35","author":"Badawy","year":"2015","journal-title":"Biosci Rep."},{"key":"B132","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00441-005-0151-7","article-title":"Quantitative and spatial differences in the expression of tryptophan-metabolizing enzymes in mouse epididymis","volume":"324","author":"Britan","year":"2006","journal-title":"Cell Tissue Res"},{"key":"B133","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1369\/0022155412458926","article-title":"Studies on tissue and cellular distribution of indoleamine 2,3-dioxygenase 2: the absence of IDO1 upregulates IDO2 expression in the epididymis","volume":"60","author":"Fukunaga","year":"2012","journal-title":"J Histochem Cytochem"},{"key":"B134","doi-asserted-by":"publisher","first-page":"e66494","DOI":"10.1371\/journal.pone.0066494","article-title":"Indoleamine 2,3-dioxygenase 1 (ido1) is involved in the control of mouse caput epididymis immune environment","volume":"8","author":"Jrad-Lamine","year":"2013","journal-title":"PLoS ONE"},{"key":"B135","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1046\/j.1365-2567.2002.01526.x","article-title":"Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division","volume":"107","author":"Lee","year":"2002","journal-title":"Immunology"},{"key":"B136","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2005.03.013","article-title":"GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase","volume":"22","author":"Munn","year":"2005","journal-title":"Immunity"},{"key":"B137","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.trim.2006.09.017","article-title":"Tryptophan catabolism generates autoimmune-preventive regulatory T cells","volume":"17","author":"Fallarino","year":"2006","journal-title":"Transpl Immunol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","article-title":"An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells","volume":"185","author":"Mezrich","year":"2010","journal-title":"J Immunol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3389\/fimmu.2017.00880","article-title":"The IDO-AhR axis controls Th17\/Treg immunity in a pulmonary model of fungal infection","volume":"8","author":"de Araujo","year":"2017","journal-title":"Front Immunol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/eji.201242779","article-title":"Kynurenine 3-monooxygenase mediates inhibition of Th17 differentiation via catabolism of endogenous aryl hydrocarbon receptor ligands","volume":"43","author":"Stephens","year":"2013","journal-title":"Eur J Immunol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/sj.cdd.4401073","article-title":"T cell apoptosis by tryptophan catabolism","volume":"9","author":"Fallarino","year":"2002","journal-title":"Cell Death Differ"},{"key":"B142","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1084\/jem.20020121","article-title":"Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase","volume":"196","author":"Frumento","year":"2002","journal-title":"J Exp Med"},{"key":"B143","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1084\/jem.20020052","article-title":"Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites","volume":"196","author":"Terness","year":"2002","journal-title":"J Exp Med"},{"key":"B144","doi-asserted-by":"publisher","first-page":"18619","DOI":"10.1073\/pnas.0709261104","article-title":"3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis","volume":"104","author":"Hayashi","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B145","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/978-1-4615-4709-9_69","article-title":"L-tryptophan-kynurenine pathway metabolite 3-hydroxyanthranilic acid induces apoptosis in macrophage-derived cells under pathophysiological conditions","volume":"467","author":"Morita","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S1074-7613(03)00266-8","article-title":"NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor","volume":"19","author":"Seman","year":"2003","journal-title":"Immunity."},{"key":"B147","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1158\/0008-5472.CAN-12-3831","article-title":"The endogenous tryptophan metabolite and NAD+ precursor quinolinic acid confers resistance of gliomas to oxidative stress","volume":"73","author":"Sahm","year":"2013","journal-title":"Cancer Res"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.18632\/oncotarget.1637","article-title":"Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR","volume":"5","author":"Litzenburger","year":"2014","journal-title":"Oncotarget"},{"key":"B149","doi-asserted-by":"publisher","first-page":"e1486353","DOI":"10.1080\/2162402X.2018.1486353","article-title":"Upregulation of tryptophanyl-tRNA synthethase adapts human cancer cells to nutritional stress caused by tryptophan degradation","volume":"7","author":"Adam","year":"2018","journal-title":"Oncoimmunology"},{"key":"B150","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1423-0127-21-17","article-title":"5-methoxyindole metabolites of L-tryptophan: control of COX-2 expression, inflammation and tumorigenesis","volume":"21","author":"Wu","year":"2014","journal-title":"J Biomed Sci"},{"key":"B151","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.it.2016.01.002","article-title":"IDO in the tumor microenvironment: inflammation, counter-regulation, and tolerance","volume":"37","author":"Munn","year":"2016","journal-title":"Trends Immunol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1600-065X.2008.00610.x","article-title":"Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape","volume":"222","author":"Katz","year":"2008","journal-title":"Immunol Rev"},{"key":"B153","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","article-title":"The three Es of cancer immunoediting","volume":"22","author":"Dunn","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"64505","DOI":"10.18632\/oncotarget.11352","article-title":"Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies","volume":"7","author":"Shou","year":"2016","journal-title":"Oncotarget"},{"key":"B155","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.4049\/jimmunol.168.8.3771","article-title":"Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses","volume":"168","author":"Mellor","year":"2002","journal-title":"J Immunol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"6985","DOI":"10.1158\/1078-0432.CCR-11-1331","article-title":"Indoleamine 2,3-dioxygenase expression in human cancers: clinical and immunologic perspectives","volume":"17","author":"Godin-Ethier","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B157","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1001\/jamaoncol.2017.1617","article-title":"Use of PD-1 targeting, macrophage infiltration, and IDO pathway activation in sarcomas: a phase 2 clinical trial","volume":"4","author":"Toulmonde","year":"2018","journal-title":"JAMA Oncol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1158\/1078-0432.CCR-13-1560","article-title":"Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an epitope derived from indoleamine 2,3 dioxygenase","volume":"20","author":"Iversen","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B159","doi-asserted-by":"publisher","first-page":"8136","DOI":"10.18632\/oncotarget.2357","article-title":"A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors","volume":"5","author":"Soliman","year":"2014","journal-title":"Oncotarget"},{"key":"B160","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1200\/JCO.2017.35.15_suppl.3003","article-title":"Epacadostat plus nivolumab in patients with advanced solid tumors: preliminary phase I\/II results of ECHO-204","volume":"35","author":"Perez","year":"2017","journal-title":"J Clin Oncol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1200\/JCO.2019.37.7_suppl.358","article-title":"BMS-986205, an indoleamine 2, 3-dioxygenase 1 inhibitor (IDO1i), in combination with nivolumab (nivo): Updated safety across all tumor cohorts and efficacy in advanced bladder cancer (advBC)","volume":"37","author":"Luke","year":"2019","journal-title":"J Clin Oncol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"180","DOI":"10.2174\/1568026619666190308131805","article-title":"Small-molecule immuno-oncology therapy: advances, challenges and new directions","volume":"19","author":"Chen","year":"2019","journal-title":"Curr Top Med Chem"},{"key":"B163","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/pbc.25156","article-title":"A phase II study to determine the efficacy and safety of oral treosulfan in patients with advanced pre-treated Ewing sarcoma ISRCTN11631773","volume":"62","author":"Michelagnoli","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"B164","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ygyno.2017.07.005","article-title":"A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)-only epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer","volume":"146","author":"Kristeleit","year":"2017","journal-title":"Gynecol Oncol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1200\/JCO.2017.35.15_suppl.1103","article-title":"Efficacy\/safety of epacadostat plus pembrolizumab in triple-negative breast cancer and ovarian cancer: Phase I\/II ECHO-202 study","volume":"35","author":"Spira","year":"2017","journal-title":"J Clin Oncol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1200\/JCO.2018.78.9602","article-title":"Epacadostat plus pembrolizumab in patients with advanced solid tumors: phase i results from a multicenter, open-label phase I\/II Trial (ECHO-202\/KEYNOTE-037)","volume":"36","author":"Mitchell","year":"2018","journal-title":"J Clin Oncol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40425-019-0562-8","article-title":"Phase 1\/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma","volume":"7","author":"Gibney","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B168","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1158\/1078-0432.CCR-18-2740","article-title":"Phase I study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) administered with PD-L1 inhibitor (atezolizumab) in advanced solid tumors","volume":"25","author":"Jung","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S1470-2045(19)30274-8","article-title":"Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301\/KEYNOTE-252): a phase 3, randomised, double-blind study","volume":"20","author":"Long","year":"2019","journal-title":"Lancet Oncol"},{"key":"B170","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00262-008-0513-6","article-title":"IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism","volume":"58","author":"Lob","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"B171","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.clinbiochem.2016.04.008","article-title":"Analysis of Kynurenine\/Tryptophan ratio and expression of IDO1 and 2 mRNA in tumour tissue of cervical cancer patients","volume":"49","author":"Hascitha","year":"2016","journal-title":"Clin Biochem"},{"key":"B172","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.4049\/jimmunol.1303012","article-title":"IDO2 is a critical mediator of autoantibody production and inflammatory pathogenesis in a mouse model of autoimmune arthritis","volume":"192","author":"Merlo","year":"2014","journal-title":"J Immunol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1158\/1078-0432.CCR-18-0814","article-title":"Host IDO2 gene status influences tumor progression and radiotherapy response in KRAS-driven sporadic pancreatic cancers","volume":"25","author":"Nevler","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B174","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature10491","article-title":"An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor","volume":"478","author":"Opitz","year":"2011","journal-title":"Nature"},{"key":"B175","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1158\/0008-5472.CAN-15-2011","article-title":"A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer","volume":"75","author":"D'Amato","year":"2015","journal-title":"Cancer Res"},{"key":"B176","doi-asserted-by":"publisher","first-page":"8169724","DOI":"10.1155\/2016\/8169724","article-title":"Expression pattern and clinicopathological relevance of the indoleamine 2,3-dioxygenase 1\/tryptophan 2,3-dioxygenase protein in colorectal cancer","volume":"2016","author":"Chen","year":"2016","journal-title":"Dis Markers"},{"key":"B177","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1073\/pnas.1113873109","article-title":"Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase","volume":"109","author":"Pilotte","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B178","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jinorgbio.2019.02.004","article-title":"Pt(IV) hybrids containing a TDO inhibitor serve as potential anticancer immunomodulators","volume":"195","author":"Hua","year":"2019","journal-title":"J Inorg Biochem"},{"key":"B179","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1158\/2326-6066.CIR-19-0041","article-title":"Inhibition of tryptophan-dioxygenase activity increases the antitumor efficacy of immune checkpoint inhibitors","volume":"8","author":"Schramme","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"B180","doi-asserted-by":"publisher","first-page":"6201764","DOI":"10.1155\/2019\/6201764","article-title":"Overexpression of kynurenine 3-monooxygenase correlates with cancer malignancy and predicts poor prognosis in canine mammary gland tumors","volume":"2019","author":"Chiu","year":"2019","journal-title":"J Oncol"},{"key":"B181","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neulet.2008.06.007","article-title":"Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma?","volume":"441","author":"Connor","year":"2008","journal-title":"Neurosci Lett"},{"key":"B182","doi-asserted-by":"publisher","first-page":"e0131389","DOI":"10.1371\/journal.pone.0131389","article-title":"Expression of the kynurenine pathway in human peripheral blood mononuclear cells: implications for inflammatory and neurodegenerative disease","volume":"10","author":"Jones","year":"2015","journal-title":"PLoS ONE"},{"key":"B183","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1021\/acsomega.7b02091","article-title":"Diclofenac identified as a kynurenine 3-monooxygenase binder and inhibitor by molecular similarity techniques","volume":"3","author":"Shave","year":"2018","journal-title":"ACS Omega"},{"key":"B184","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3332\/ecancer.2016.610","article-title":"Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent","volume":"10","author":"Pantziarka","year":"2016","journal-title":"Ecancermedicalscience"},{"key":"B185","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/0269216307085183","article-title":"Fatigue in palliative care patients \u2013 an EAPC approach","volume":"22","author":"Radbruch","year":"2008","journal-title":"Palliat Med"},{"key":"B186","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.6004\/jnccn.2015.0122","article-title":"Cancer-related fatigue, version 2","volume":"13","author":"Berger","year":"2015","journal-title":"J Natl Compr Canc Netw."},{"key":"B187","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrclinonc.2014.127","article-title":"Cancer-related fatigue\u2013mechanisms, risk factors, and treatments","volume":"11","author":"Bower","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"B188","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1097\/00006842-200207000-00010","article-title":"Fatigue and proinflammatory cytokine activity in breast cancer survivors","volume":"64","author":"Bower","year":"2002","journal-title":"Psychosom Med."},{"key":"B189","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.bbi.2012.05.004","article-title":"A systematic review of the association between immunogenomic markers and cancer-related fatigue","volume":"26","author":"Saligan","year":"2012","journal-title":"Brain Behav Immun"},{"key":"B190","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1016\/j.bbi.2012.06.011","article-title":"Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications","volume":"30","author":"Bower","year":"2013","journal-title":"Brain Behav Immun."},{"key":"B191","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.bbi.2007.12.011","article-title":"Quality of life and immune activation in patients with HIV-infection","volume":"22","author":"Schroecksnadel","year":"2008","journal-title":"Brain Behav Immun"},{"key":"B192","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/978-1-4615-0135-0_39","article-title":"Tryptophan and quality of life in colorectal cancer","volume-title":"Developments in Tryptophan and Serotonin Metabolism","author":"Huang","year":"2003"},{"key":"B193","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/cncr.29302","article-title":"Inflammation-induced activation of the indoleamine 2,3-dioxygenase pathway: relevance to cancer-related fatigue","volume":"121","author":"Kim","year":"","journal-title":"Cancer. ("},{"key":"B194","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1200\/JCO.2012.44.4661","article-title":"Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer","volume":"31","author":"Yennurajalingam","year":"2013","journal-title":"J Clin Oncol"},{"key":"B195","doi-asserted-by":"publisher","first-page":"e16234","DOI":"10.1097\/MD.0000000000016234","article-title":"A comprehensive evaluation of clinical efficacy and safety of celecoxib in combination with chemotherapy in metastatic or postoperative recurrent gastric cancer patients: a preliminary, three-center, clinical trial study","volume":"98","author":"Guo","year":"2019","journal-title":"Medicine."},{"key":"B196","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.tins.2013.10.003","article-title":"The neuroimmune basis of fatigue","volume":"37","author":"Dantzer","year":"2014","journal-title":"Trends Neurosci"},{"key":"B197","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(05)67763-X","article-title":"Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial","volume":"367","author":"Tyring","year":"2006","journal-title":"Lancet"},{"key":"B198","first-page":"838","article-title":"Adalimumab plus methotrexate or standard therapy is more effective than methotrexate or standard therapies alone in the treatment of fatigue in patients with active, inadequately treated rheumatoid arthritis","volume":"25","author":"Yount","year":"2007","journal-title":"Clin Exp Rheumatol."},{"key":"B199","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s11136-005-4324-3","article-title":"Assessment of anxiety and depression in advanced cancer patients and their relationship with quality of life","volume":"14","author":"Mystakidou","year":"2005","journal-title":"Qual Life Res"},{"key":"B200","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1007\/s11764-013-0286-6","article-title":"Depressive symptoms are a risk factor for all-cause mortality: results from a prospective population-based study among 3,080 cancer survivors from the PROFILES registry","volume":"7","author":"Mols","year":"2013","journal-title":"J Cancer Surviv."},{"key":"B201","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ctrv.2016.11.004","article-title":"Depression in cancer: The many biobehavioral pathways driving tumor progression","volume":"52","author":"Bortolato","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"B202","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/MCO.0b013e328340d849","article-title":"Association between increased tryptophan degradation and depression in cancer patients","volume":"14","author":"Kurz","year":"2011","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"B203","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/FBP.0000000000000384","article-title":"Tryptophan catabolites along the indoleamine 2,3-dioxygenase pathway as a biological link between depression and cancer","volume":"29","author":"Barreto","year":"2018","journal-title":"Behav Pharmacol."},{"key":"B204","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1007\/s00213-019-05200-8","article-title":"Inflammation in cancer and depression: a starring role for the kynurenine pathway","volume":"236","author":"Sforzini","year":"2019","journal-title":"Psychopharmacology"},{"key":"B205","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/sj.mp.4002148","article-title":"Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice","volume":"14","author":"O'Connor","year":"2009","journal-title":"Mol Psychiatry"},{"key":"B206","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.physbeh.2014.12.045","article-title":"Fluoxetine prevents the development of depressive-like behavior in a mouse model of cancer related fatigue","volume":"140","author":"Norden","year":"2015","journal-title":"Physiol Behav"},{"key":"B207","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.psyneuen.2018.05.019","article-title":"Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes","volume":"95","author":"Doolin","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"B208","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbi.2015.02.007","article-title":"Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder","volume":"46","author":"Savitz","year":"2015","journal-title":"Brain Behav Immun"},{"key":"B209","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bbi.2015.11.003","article-title":"Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder","volume":"53","author":"Meier","year":"2016","journal-title":"Brain Behav Immun"},{"key":"B210","doi-asserted-by":"publisher","first-page":"e918","DOI":"10.1038\/tp.2016.200","article-title":"Neurotoxic kynurenine metabolism is increased in the dorsal hippocampus and drives distinct depressive behaviors during inflammation","volume":"6","author":"Parrott","year":"2016","journal-title":"Transl Psychiatry"},{"key":"B211","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.4049\/jimmunol.0802722","article-title":"Induction of IDO by bacille Calmette-Guerin is responsible for development of murine depressive-like behavior","volume":"182","author":"O'Connor","year":"2009","journal-title":"J Immunol"},{"key":"B212","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1038\/s41386-018-0154-1","article-title":"Resolution of inflammation-induced depression requires T lymphocytes and endogenous brain interleukin-10 signaling","volume":"43","author":"Laumet","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"B213","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/QAI.0000000000000062","article-title":"Reversal of the Kynurenine pathway of tryptophan catabolism may improve depression in ART-treated HIV-infected Ugandans","volume":"65","author":"Martinez","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B214","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/sj.mp.4000872","article-title":"Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation","volume":"6","author":"Maes","year":"2001","journal-title":"Mol Psychiatry"},{"key":"B215","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.yfrne.2012.09.003","article-title":"Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise","volume":"33","author":"Felger","year":"2012","journal-title":"Front Neuroendocrinol"},{"key":"B216","doi-asserted-by":"publisher","first-page":"622","DOI":"10.2174\/138920008785821738","article-title":"Chronic immune stimulation correlates with reduced phenylalanine turnover","volume":"9","author":"Neurauter","year":"2008","journal-title":"Curr Drug Metab."},{"key":"B217","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1126\/science.173.3992.149","article-title":"Brain serotonin content: physiological dependence on plasma tryptophan levels","volume":"173","author":"Fernstrom","year":"1971","journal-title":"Science."},{"key":"B218","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/sj.mp.4001600","article-title":"IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity","volume":"10","author":"Wichers","year":"2005","journal-title":"Mol Psychiatry"},{"key":"B219","doi-asserted-by":"publisher","first-page":"104024","DOI":"10.1155\/2013\/104024","article-title":"Quinolinic acid: an endogenous neurotoxin with multiple targets","volume":"2013","author":"Lugo-Huitron","year":"2013","journal-title":"Oxid Med Cell Longev."},{"key":"B220","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1042\/bst0130441","article-title":"Kynurenine hydroxylase: a potential rate-limiting enzyme in tryptophan metabolism","volume":"13","author":"Bender","year":"1985","journal-title":"Biochem Soc Trans."},{"key":"B221","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/0014-4886(84)90239-5","article-title":"Studies on the disposition of quinolinic acid after intracerebral or systemic administration in the rat","volume":"84","author":"Foster","year":"1984","journal-title":"Exp Neurol."},{"key":"B222","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/0006-8993(82)91048-4","article-title":"An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid","volume":"247","author":"Perkins","year":"1982","journal-title":"Brain Res."},{"key":"B223","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0304-3940(84)90050-8","article-title":"Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid","volume":"48","author":"Foster","year":"1984","journal-title":"Neurosci Lett."},{"key":"B224","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4103\/1673-5374.198971","article-title":"Kynurenine pathway metabolism and neuroinflammatory disease","volume":"12","author":"Braidy","year":"2017","journal-title":"Neural Regen Res"},{"key":"B225","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/j.1742-4658.2012.08551.x","article-title":"Kynurenines: from the perspective of major psychiatric disorders","volume":"279","author":"Myint","year":"2012","journal-title":"FEBS J"},{"key":"B226","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11011-008-9114-5","article-title":"Neuropsychiatric disorders related to interferon and interleukins treatment","volume":"24","author":"Myint","year":"2009","journal-title":"Metab Brain Dis"},{"key":"B227","doi-asserted-by":"publisher","first-page":"12420","DOI":"10.1021\/bi8010434","article-title":"Kynurenine 3-monooxygenase from Pseudomonas fluorescens: substrate-like inhibitors both stimulate flavin reduction and stabilize the flavin-peroxo intermediate yet result in the production of hydrogen peroxide","volume":"47","author":"Crozier-Reabe","year":"2008","journal-title":"Biochemistry"},{"key":"B228","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1093\/jnci\/djt242","article-title":"Recommendations for high-priority research on cancer-related fatigue in children and adults","volume":"105","author":"Barsevick","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"B229","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","article-title":"Depression","volume":"392","author":"Malhi","year":"2018","journal-title":"Lancet"},{"key":"B230","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1007\/s11064-017-2329-2","article-title":"Activation of brain indoleamine-2,3-dioxygenase contributes to depressive-like behavior induced by an intracerebroventricular injection of streptozotocin in mice","volume":"42","author":"Souza","year":"2017","journal-title":"Neurochem Res"},{"key":"B231","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bbi.2015.12.020","article-title":"Mouse chronic social stress increases blood and brain kynurenine pathway activity and fear behaviour: Both effects are reversed by inhibition of indoleamine 2,3-dioxygenase","volume":"54","author":"Fuertig","year":"2016","journal-title":"Brain Behav Immun"},{"key":"B232","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1742-2094-11-41","article-title":"Activation of brain indoleamine 2,3-dioxygenase contributes to epilepsy-associated depressive-like behavior in rats with chronic temporal lobe epilepsy","volume":"11","author":"Xie","year":"2014","journal-title":"J Neuroinflamm"},{"key":"B233","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1684\/ecn.2015.0362","article-title":"TNF\u03b1 mediates stress-induced depression by upregulating indoleamine 2,3-dioxygenase in a mouse model of unpredictable chronic mild stress","volume":"26","author":"Liu","year":"2015","journal-title":"Eur Cytok Netw"},{"key":"B234","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41598-018-36507-9","article-title":"The antidepressant impact of minocycline in rodents: a systematic review and meta-analysis","volume":"9","author":"Reis","year":"2019","journal-title":"Sci Rep"},{"key":"B235","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1742-2094-5-15","article-title":"Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia","volume":"5","author":"Henry","year":"2008","journal-title":"J Neuroinflamm"},{"key":"B236","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cyto.2017.12.013","article-title":"The effect of minocycline on indolamine 2, 3 dioxygenase expression and the levels of kynurenic acid and quinolinic acid in LPS-activated primary rat microglia","volume":"107","author":"Bahrami","year":"2018","journal-title":"Cytokine"},{"key":"B237","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12868-018-0460-x","article-title":"Anti-inflammatory effects of minocycline are mediated by retinoid signaling","volume":"19","author":"Clemens","year":"2018","journal-title":"BMC Neurosci"},{"key":"B238","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jad.2017.10.042","article-title":"Efficacy and tolerability of minocycline for depression: a systematic review and meta-analysis of clinical trials","volume":"227","author":"Rosenblat","year":"2018","journal-title":"J Affect Disord"},{"key":"B239","doi-asserted-by":"publisher","first-page":"732","DOI":"10.2174\/1570159X14666151208113700","article-title":"Inflammation in depression and the potential for anti-inflammatory treatment","volume":"14","author":"Kohler","year":"2016","journal-title":"Curr Neuropharmacol"},{"key":"B240","doi-asserted-by":"publisher","first-page":"1178646919872508","DOI":"10.1177\/1178646919872508","article-title":"Inhibition of indoleamine 2,3 dioxygenase does not improve cancer-related symptoms in a murine model of human papilloma virus-related head and neck cancer","volume":"12","author":"Vichaya","year":"","journal-title":"Int J Tryptophan Res."},{"key":"B241","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/0006-2952(95)00006-L","article-title":"The effects of a novel and selective inhibitor of tryptophan 2,3-dioxygenase on tryptophan and serotonin metabolism in the rat","volume":"49","author":"Salter","year":"1995","journal-title":"Biochem Pharmacol."},{"key":"B242","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1073\/pnas.1604453113","article-title":"Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites","volume":"113","author":"Breda","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B243","doi-asserted-by":"publisher","first-page":"36554","DOI":"10.1074\/jbc.M113.503813","article-title":"Targeted deletion of kynurenine 3-monooxygenase in mice: a new tool for studying kynurenine pathway metabolism in periphery and brain","volume":"288","author":"Giorgini","year":"2013","journal-title":"J Biol Chem"},{"key":"B244","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.bbi.2017.02.010","article-title":"Desipramine decreases expression of human and murine indoleamine-2,3-dioxygenases","volume":"62","author":"Brooks","year":"2017","journal-title":"Brain Behav Immun"},{"key":"B245","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.intimp.2019.05.039","article-title":"Interaction of the immune-inflammatory and the kynurenine pathways in rats resistant to antidepressant treatment in model of depression","volume":"73","author":"Duda","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B246","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.bbi.2017.05.006","article-title":"Rescue of IL-1beta-induced reduction of human neurogenesis by omega-3 fatty acids and antidepressants","volume":"65","author":"Borsini","year":"2017","journal-title":"Brain Behav Immun"},{"key":"B247","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neurol.2019.08.005","article-title":"Mediterranean diet: the role of long-chain \u03c9-3 fatty acids in fish; polyphenols in fruits, vegetables, cereals, coffee, tea, cacao and wine; probiotics and vitamins in prevention of stroke, age-related cognitive decline, and Alzheimer disease","volume":"175","author":"Rom\u00e1n","year":"2019","journal-title":"Rev Neurol"},{"key":"B248","doi-asserted-by":"publisher","first-page":"E1063","DOI":"10.3390\/nu9101063","article-title":"Adherence to mediterranean diet and risk of cancer: an updated systematic review and meta-analysis","volume":"9","author":"Schwingshackl","year":"2017","journal-title":"Nutrients."},{"key":"B249","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1475-2891-13-61","article-title":"Fast food fever: reviewing the impacts of the Western diet on immunity","volume":"13","author":"Myles","year":"2014","journal-title":"Nutr J"},{"key":"B250","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bbi.2014.03.012","article-title":"Diet-induced obesity progressively alters cognition, anxiety-like behavior and lipopolysaccharide-induced depressive-like behavior: focus on brain indoleamine 2,3-dioxygenase activation","volume":"41","author":"Andr\u00e9","year":"2014","journal-title":"Brain Behav Immun"},{"key":"B251","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","article-title":"Gut microbiota regulation of tryptophan metabolism in health and disease","volume":"23","author":"Agus","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B252","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jcmgh.2018.04.003","article-title":"The brain-gut-microbiome axis","volume":"6","author":"Martin","year":"2018","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B253","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.cell.2018.03.013","article-title":"Beyond host defense: emerging functions of the immune system in regulating complex tissue physiology","volume":"173","author":"Rankin","year":"2018","journal-title":"Cell"},{"key":"B254","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.1007\/s00018-019-03190-6","article-title":"Bridging intestinal immunity and gut microbiota by metabolites","volume":"76","author":"Wang","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2019.06.026","article-title":"Ketogenic diet in the treatment of cancer - where do we stand?","author":"Weber","year":"2019","journal-title":"Mol Metab"},{"key":"B256","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/jhn.12587","article-title":"A systematic review of the use of ketogenic diets in adult patients with cancer","volume":"31","author":"Sremanakova","year":"2018","journal-title":"J Hum Nutr Diet"},{"key":"B257","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1194\/jlr.M079251","article-title":"Regulation of kynurenine metabolism by a ketogenic diet","volume":"59","author":"Heischmann","year":"2018","journal-title":"J Lipid Res"},{"key":"B258","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00702-011-0750-2","article-title":"Ketogenic diet increases concentrations of kynurenic acid in discrete brain structures of young and adult rats","volume":"119","author":"Zarnowski","year":"2012","journal-title":"J Neural Transm."},{"key":"B259","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.2174\/0929867324666170509120257","article-title":"Kynurenic acid and neuroprotective activity of the ketogenic diet in the eye","volume":"24","author":"Zarnowski","year":"2017","journal-title":"Curr Med Chem"},{"key":"B260","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.seizure.2019.05.006","article-title":"Changes in tryptophan and kynurenine pathway metabolites in the blood of children treated with ketogenic diet for refractory epilepsy","volume":"69","author":"Zarnowska","year":"2019","journal-title":"Seizure."},{"key":"B261","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1093\/ajcn\/nqz169","article-title":"Plasma metabolomics profiles suggest beneficial effects of a low-glycemic load dietary pattern on inflammation and energy metabolism","volume":"110","author":"Navarro","year":"2019","journal-title":"Am J Clin Nutr"},{"key":"B262","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/01635581.2018.1513046","article-title":"Nutritional interventions for treating cancer-related fatigue: a qualitative review","volume":"71","author":"Inglis","year":"2019","journal-title":"Nutr Cancer"},{"key":"B263","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/s41568-018-0061-0","article-title":"Fasting and cancer: molecular mechanisms and clinical application","volume":"18","author":"Nencioni","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B264","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.dld.2014.09.004","article-title":"Effects of 12 weeks of probiotic supplementation on quality of life in colorectal cancer survivors: a double-blind, randomized, placebo-controlled trial","volume":"46","author":"Lee","year":"2014","journal-title":"Dig Liver Dis"},{"key":"B265","doi-asserted-by":"publisher","first-page":"219","DOI":"10.6004\/jadpro.2013.4.4.3","article-title":"Complementary strategies for the management of radiation therapy side effects","volume":"4","author":"Stubbe","year":"2013","journal-title":"J Adv Pract Oncol."},{"key":"B266","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.psyneuen.2018.10.010","article-title":"Probiotic Lactobacillus plantarum 299v decreases kynurenine concentration and improves cognitive functions in patients with major depression: a double-blind, randomized, placebo controlled study","volume":"100","author":"Rudzki","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"B267","doi-asserted-by":"publisher","first-page":"E752","DOI":"10.3390\/nu8110752","article-title":"Probiotic supplements beneficially affect tryptophan-kynurenine metabolism and reduce the incidence of upper respiratory tract infections in trained athletes: a randomized, double-blinded, placebo-controlled trial","volume":"8","author":"Strasser","year":"2016","journal-title":"Nutrients."},{"key":"B268","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.2174\/1389200219666180813144834","article-title":"Probiotic supplementation in patients with Alzheimer's dementia - an explorative intervention study","volume":"15","author":"Leblhuber","year":"2018","journal-title":"Curr Alzheimer Res"},{"key":"B269","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","article-title":"Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22","volume":"39","author":"Zelante","year":"2013","journal-title":"Immunity."},{"key":"B270","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bbi.2018.07.006","article-title":"Probiotics for the treatment of depressive symptoms: an anti-inflammatory mechanism?","volume":"73","author":"Park","year":"2018","journal-title":"Brain Behav Immun"},{"key":"B271","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12991-017-0138-2","article-title":"The effects of probiotics on depressive symptoms in humans: a systematic review","volume":"16","author":"Wallace","year":"2017","journal-title":"Ann Gen Psychiatry"},{"key":"B272","doi-asserted-by":"publisher","first-page":"2045125319859963","DOI":"10.1177\/2045125319859963","article-title":"Gut feeling: randomized controlled trials of probiotics for the treatment of clinical depression: systematic review and meta-analysis","volume":"9","author":"Nikolova","year":"2019","journal-title":"Ther Adv Psychopharmacol."},{"key":"B273","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1017\/S000711451800363X","article-title":"Nutrition therapy for the management of cancer-related fatigue and quality of life: a systematic review and meta-analysis","volume":"122","author":"Baguley","year":"2019","journal-title":"Br J Nutr"},{"key":"B274","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.physbeh.2018.07.015","article-title":"Acute and chronic effects of exercise on the kynurenine pathway in humans - a brief review and future perspectives","volume":"194","author":"Metcalfe","year":"2018","journal-title":"Physiol Behav"},{"key":"B275","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000496293","article-title":"Tryptophan metabolism and related pathways in psychoneuroimmunology: the impact of nutrition and lifestyle","volume":"79","author":"Gostner","year":"","journal-title":"Neuropsychobiology."},{"key":"B276","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.2174\/1871527313666140612102841","article-title":"Effects of exercise on anxiety and depression disorders: review of meta- analyses and neurobiological mechanisms","volume":"13","author":"Wegner","year":"2014","journal-title":"CNS Neurol Dis Drug Targets"},{"key":"B277","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1007\/s40279-014-0150-5","article-title":"Exercise, nutrition and the brain","volume":"44","author":"Meeusen","year":"2014","journal-title":"Sports Med."},{"key":"B278","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-3-319-72790-5_7","article-title":"Tryptophan-kynurenine metabolites in exercise and mental health","volume-title":"Hormones, Metabolism and the Benefits of Exercise","author":"Valente-Silva","year":"2017"},{"key":"B279","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cell.2014.07.051","article-title":"Skeletal muscle PGC-1\u03b11 modulates kynurenine metabolism and mediates resilience to stress-induced depression","volume":"159","author":"Agudelo","year":"2014","journal-title":"Cell"},{"key":"B280","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/0090-1229(92)90012-D","article-title":"Enhanced release of cytokines, interleukin-2 receptors, and neopterin after long-distance running","volume":"63","author":"Sprenger","year":"1992","journal-title":"Clin Immunol Immunopathol"},{"key":"B281","first-page":"117","article-title":"Psychological outcomes associated with anemia-related fatigue in cancer patients","volume":"16","author":"Kallich","year":"2002","journal-title":"Oncology"},{"key":"B282","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1634\/theoncologist.5-suppl_2-19","article-title":"The relationship between anemia and quality of life in cancer patients","volume":"5","author":"Sabbatini","year":"2000","journal-title":"Oncologist."},{"key":"B283","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.amjmed.2003.12.008","article-title":"Prevalence and outcomes of anemia in cancer: a systematic review of the literature","volume":"116","author":"Knight","year":"2004","journal-title":"Am J Med."},{"key":"B284","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss","year":"2005","journal-title":"N Engl J Med"},{"key":"B285","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJMra1804281","article-title":"Anemia of Inflammation","volume":"381","author":"Ganz","year":"2019","journal-title":"N Engl J Med"},{"key":"B286","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/blood-2018-06-856500","article-title":"Anemia of inflammation","volume":"133","author":"Weiss","year":"2019","journal-title":"Blood"},{"key":"B287","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1515\/pteridines.2010.21.1.29","article-title":"Iron metabolic changes and immune activation in patients with HIV-1 infection before and after ART","volume":"21","author":"Kurz","year":"2010","journal-title":"Pteridines"},{"key":"B288","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.imbio.2009.05.004","article-title":"Inflammatory biomarker, neopterin, predominantly enhances myelopoiesis, which suppresses erythropoiesis via activated stromal cells","volume":"215","author":"Tsuboi","year":"2010","journal-title":"Immunobiology."},{"key":"B289","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.exphem.2015.08.010","article-title":"Kynurenine, by activating aryl hydrocarbon receptor, decreases erythropoietin and increases hepcidin production in HepG2 cells: a new mechanism for anemia of inflammation","volume":"44","author":"Eleftheriadis","year":"2016","journal-title":"Exp Hematol."},{"key":"B290","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1158\/0008-5472.CAN-12-0569","article-title":"Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion","volume":"72","author":"Platten","year":"2012","journal-title":"Cancer Res."},{"key":"B291","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1046\/j.0902-4441.2003.00197.x","article-title":"Possible role of cytokine-induced tryptophan degradation in anaemia of inflammation","volume":"72","author":"Weiss","year":"2004","journal-title":"Eur J Haematol"},{"key":"B292","doi-asserted-by":"publisher","first-page":"F693","DOI":"10.1152\/ajprenal.00327.2002","article-title":"Contribution of quinolinic acid in the development of anemia in renal insufficiency","volume":"284","author":"Pawlak","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"B293","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12640-009-9051-z","article-title":"Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons","volume":"16","author":"Braidy","year":"2009","journal-title":"Neurotox Res"},{"key":"B294","doi-asserted-by":"publisher","first-page":"9038","DOI":"10.1074\/jbc.274.13.9038","article-title":"Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling","volume":"274","author":"Huang","year":"1999","journal-title":"J Biol Chem"},{"key":"B295","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1016\/j.celrep.2019.02.071","article-title":"Enhanced renewal of erythroid progenitors in myelodysplastic anemia by peripheral serotonin","volume":"26","author":"Sibon","year":"2019","journal-title":"Cell Rep."},{"key":"B296","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/acps.12595","article-title":"Association between depression and anemia in otherwise healthy adults","volume":"134","author":"Vulser","year":"2016","journal-title":"Acta Psychiatr Scand"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00249\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T05:32:35Z","timestamp":1614490355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00249\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,21]]},"references-count":296,"alternative-id":["10.3389\/fimmu.2020.00249"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00249","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,21]]},"article-number":"249"}}